Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

ENROLLING BY INVITATION

Identifier: CI-TRIAL-00122567
Entity page: /trial/NCT07620574 ↗
Edges: 13

Neighbours: 7 cancers6 drugs
Drawn: 13 of 13 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study condition of …CONDITION_OFderived7 of 7
← condition of	Hepatocellular Carcinoma registry condition “Hepatocellular Carcinoma (HCC)” mapped ONTOLOGY_EXACT	—	—	Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
← condition of	Malignant Colorectal Neoplasm registry condition “Colorectal Cancer” mapped CURATED_BROADER	—

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study intervention of …INTERVENTION_OFderived6 of 6
← intervention of	Abirateronesmall molecule registry intervention “Abiraterone” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Atezolizumabmonoclonal antibody registry intervention “Atezolizumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Cabozantinibsmall molecule registry intervention “Cabozantinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Enzalutamidesmall molecule registry intervention “Enzalutamide” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Nivolumabmonoclonal antibody registry intervention “Nivolumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Prednisonesmall molecule registry intervention “Prednisone” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study intervention of …INTERVENTION_OFderived6 of 6

← intervention of

Abirateronesmall molecule

registry intervention “Abiraterone” (DRUG) mapped ALIAS

—

not mapped

Observed

clinicaltrials

graph →

← intervention of

Atezolizumabmonoclonal antibody

registry intervention “Atezolizumab” (DRUG) mapped ALIAS